Analysts' Downgrades for June 2nd (AGLE, AI, ALB, ANF, APTS, AUY, BBAJF, CCI, CMCSA, CTS)
Analysts’ downgrades for Thursday, June 2nd: Aeglea BioTherapeutics (NASDAQ:AGLE) was downgraded by analysts at Piper Sandler from an overweight rating to a neutral rating. They currently have $1.00 price target on the stock, down from their previous price target of $4.00. C3.ai (NYSE:AI) was downgraded by analysts at Piper Sandler from an overweight rating to […]
Source: etfdailynews.com